AC
NRXPW

Athanor Capital’s NRX Pharmaceuticals Warrant NRXPW Stock Holding History

Athanor Capital’s Portfolio NRXPW Stock Details NRXPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-14,989
Closed -$531K – 652
2021
Q1 		$531K Buy
+14,989
New +$122K 0.01% 466

Other funds holding NRXPW

AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return

Athanor Capital's NRXPW Position: Q2 2021 in Review

Athanor Capital sold out of NRX Pharmaceuticals Warrant (NRXPW) in Q2 2021, closing a stake of 14,989 shares — an estimated $531K sold.

Athanor Capital first reported a position in NRXPW in Q1 2021 and held it in 1 quarter. The position peaked at $531K in Q1 2021. 4 funds tracked by Wall St. Rank hold NRXPW as of Q2 2021.

  • Athanor Capital reported no remaining NRX Pharmaceuticals Warrant position as of Q2 2021 after selling out during the quarter.
  • Athanor Capital sold 14,989 NRX Pharmaceuticals Warrant shares in Q2 2021, an estimated $531K.
  • Athanor Capital first reported a position in NRX Pharmaceuticals Warrant in Q1 2021 and held it in 1 quarter.
  • Athanor Capital's NRX Pharmaceuticals Warrant position peaked at $531K in Q1 2021.
  • 4 funds tracked by Wall St. Rank held NRX Pharmaceuticals Warrant as of Q2 2021.

Based on Athanor Capital's 13F filing for Q2 2021, filed 16 Aug 2021.